Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil and Carboplatin in Advanced or Recurrent Endometrial Carcinoma
NCT00470067Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Feb 2007
- Primary completion
- May 2008
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in endometrial carcinoma, sponsored by Roswell Park Comprehensive Cancer Center. Started Feb 2007; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00470067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470067.